A
reconciliation between the Company’s effective tax rate and the federal statutory rate for the year ended March 31, 2026 is as
follows (amounts in thousands of dollars):
SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION
| | |
Amount | | |
Percent | |
| | |
2026 | |
| | |
Amount | | |
Percent | |
| U.S. Federal Statutory Tax Rate | |
$ | 11,682 | | |
| 21.00 | % |
| State and Local Income Taxes, Net of Federal Income Tax Effect (a) | |
| 1,313 | | |
| 2.36 | % |
| Foreign Tax Effects | |
| — | | |
| — | % |
| Effect of Changes in Tax Law or Rates Enacted in the Current Period | |
| — | | |
| — | % |
| Effect of Cross-Border Tax Laws | |
| — | | |
| — | % |
| Tax Credits | |
| — | | |
| — | % |
| Federal R&D Credits | |
| (360 | ) | |
| (0.65 | )% |
| Prior year deferred true-up | |
| | | |
| | |
| Changes in Valuation Allowance | |
| — | | |
| — | % |
| Nontaxable or Nondeductible Items | |
| — | | |
| — | % |
| Non-deductible change in fair value of derivative financial instruments | |
| (1,650 | ) | |
| (2.96 | )% |
| Non-deductible change in fair value of stock-based liabilities | |
| | | |
| | |
| Officer’s compensation | |
| 1,143 | | |
| 2.05 | % |
| Other | |
| (186 | ) | |
| (0.33 | )% |
| Other permanent items | |
| | | |
| | |
| Changes in Unrecognized Tax Benefits | |
| — | | |
| — | % |
| Other Adjustments | |
| — | | |
| — | % |
| Other | |
| — | | |
| — | % |
| Effective Tax Rate | |
$ | 11,942 | | |
| 21.47 | % |
| (a) | | State taxes in
New Jersey and Florida made up the majority (greater than 50 percent) of the tax effect in this category. |
A
reconciliation between the Company’s effective tax rate and the federal statutory rate for the year ended March 31, 2025 is as
follows:
| For the Year Ended March 31 (in thousands) | |
2025 | |
| Federal income tax rate | |
$ | (11 | ) |
| U.S. Federal Statutory Tax Rate | |
$ | (11 | ) |
| State and local taxes, net of federal benefit | |
| 293 | |
| State and Local Income Taxes, Net of Federal Income Tax Effect | |
| 293 | |
| Non-deductible change in fair value of derivative financial instruments | |
| 3,969 | |
| Non-deductible change in fair value of stock-based liabilities | |
| — | |
| Other permanent items | |
| 17 | |
| Prior year deferred true-up | |
| 110 | |
| Tax credits | |
| (115 | ) |
| Federal R&D Credits | |
| (115 | ) |
| Change in valuation allowance | |
| — | |
| Changes in Valuation Allowance | |
| — | |
| Effective tax rate | |
$ | 4,263 | |
| Effective Tax Rate | |
$ | 4,263 | |
|